RARA CRAFT DATABASE for FDA Medical Devices
510(k)K260355

FDA DEVICE FACTS

Webest Multi-Drug Urine Cup; Webest Home Multi-Drug Urine Cup

WEBEST Biotech,, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 9, 2026PRODUCT CODENFT

Indications for use

The Webest Home Multi-Drug Urine Cup is lateral flow immunoassays for rapid detection of multiple commonly abused drugs in human urine. The detectable drugs and their cutoff concentrations are listed below: CODE SUBSTANCE CUT-OFF (ng/mL) AMP D-Amphetamine 1000 or 500 BAR Butalbital 300 BUP Buprenorphine 10 BZO Oxazepam 300 COC Benzoylecgonine 300 or150 EDDP 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine 300 FYL Fentanyl 1 MDMA Methylenedioxymethamphetamine 500 MET D-Methamphetamine 1000 or 500 MTD Methadone 300 6-MAM 6-Monoacetylmorphine 10 NFYL Norfentanyl 5 MOP/OPI Morphine 2000 or300 OXY Oxycodone 100 PCP Phencyclidine 25 PPX D-Propoxyphene 300 TCA Nortriptyline 1000 THC 11-nor-Δ9-THC-COOH 50 TML Tramadol 100 This is not a screening device to monitor prescription medication. The single or multi-test cup can include any combination of the analytes listed above, with and without on-board adulteration tests. However, only one cut-off concentration can be included per analyte per device. This device provides only a preliminary test result. A more specific alternate method shall be used in order to obtain a confirmed analytical test result. GC/MS or LC/MS is the preferred confirmatory method. The WEBEST Multi-Drug Urine Cup is a rapid lateral flow immunoassays for the qualitative detection of D-Amphetamine, Butalbital ,Buprenorphine, Oxazepam, Benzoylecgonine, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, Fentanyl, Methylenedioxymethamphetamine , D-Methamphetamine, Methadone, 6-Monoacetylmorphine, Norfentanyl, Morphine, Oxycodone, Phencyclidine, D-Propoxyphene, Nortriptyline, 11-nor-Δ9-THC-COOH and Tramadol in human urine. The test cut-off concentrations and the compounds the tests are calibrated to are as follows: Test Calibrator Cut-off (ng/mL) AMP D-Amphetamine 1000 or 500 BAR Butalbital 300 BUP Buprenorphine 10 BZO Oxazepam 300 COC Benzoylecgonine 300 or 150 EDDP 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine 300 FYL Fentanyl 1 MDMA Methylenedioxymethamphetamine 500 MET D-Methamphetamine 1000 or 500 MTD Methadone 300 6-MAM 6-Monoacetylmorphine 10 NFYL Norfentanyl 5 MOP/OPI Morphine 2000 or 300 OXY Oxycodone 100 PCP Phencyclidine 25 PPX D-Propoxyphene 300 TCA Nortriptyline 1000 THC 11-nor-Δ9-THC-COOH 50 TML Tramadol 100 The single or multi-test cup can consist of up to nineteen (19) of the above listed analytes in any combination with or without on-board adulteration/ specimen validity tests (SVT). The tests provide only a preliminary result. A more specific alternative chemical method must be used to obtain a confirmed positive result. Gas Chromatography-Mass Spectrometry (GC- MS), Liquid Chromatography-Mass Spectrometry (LC-MS), and their tandem mass-spectrometer versions are the preferred confirmatory methods. Careful consideration and judgment should be applied to any drugs of abuse screen test result, particularly when evaluating preliminary positive results.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026